🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

478 results for “capsule” Clear

  1. Topiramate 25 mg Capsules

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  2. Topiramate Capsules, 25 mg

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  3. Yimitasvir Phosphate Capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  4. Zaleplon 10 mg Capsules

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  5. [14C]-Paxalisib Capsule

    KAZIA THERAPEUTICS LTD

    Healthy

    phase 1 small molecule completed

    1 trial

  6. pyroglutamate rongliflozin capsules

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes

    phase 1 small molecule completed

    1 trial

  7. pyroglutamate rongliflozin capsules

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetes Mellitus, Type 2

    phase 1 small molecule completed

    1 trial

  8. Alecensa 150 mg hard capsules

    Disc Medicine

    ALK positive non-small cell lung cancer

    approved small molecule active

    1 trial

  9. Amoxicillin 500 mg film-coated tablets, Placebo amoxicillin capsules 500mg

    Disc Medicine

    non-specific low back pain

    approved small molecule active

    1 trial

  10. Babaodan oral capsule

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    approved small molecule active

    1 trial

  11. Braftovi 50 mg hard capsules, Zelboraf 240 mg film-coated tablets, Encorafenib, Erbitux 5 mg/mL solution for infusion, PEMBROLIZUMAB, Braftovi 75 mg hard capsules, Braftovi 75 mg hard capsules, Braftovi 50 mg hard capsules, Ribociclib, Ribociclib, NIVOLUMAB, Mektovi 15 mg film-coated tablets, Mektovi 15 mg film-coated tablets, Ribociclib

    Pfizer Australia Pty Ltd

    Solid tumors

    approved small molecule active

    1 trial

  12. Capsules with microcrystalline cellulose, Colchicine Teva 0,5 mg, tabletten

    Disc Medicine

    Type 1 Diabetes

    approved small molecule active

    1 trial

  13. Cormeto 250 mg capsule molli

    Istituto Gentili S.r.l.

    patients with adrenal incidentalomas and subclinical/mild Cushing’s syndrome

    approved small molecule active

    1 trial

  14. Cufence 200 mg hard capsules

    Univar Solutions BV

    Wilson’s Disease

    approved small molecule active

    1 trial

  15. Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets

    Disc Medicine

    chemotherapy-induced neuropathic pain

    approved small molecule active

    1 trial

  16. Dengzhan Shengmai capsule

    Universal Integrated

    Stroke

    approved small molecule completed

    1 trial

  17. Deutetrabenazine Oral Capsule

    Teva Pharma GmbH

    Tardive Dyskinesia

    approved small molecule active

    1 trial

  18. ESTECLIN 300 MG CAPSULE RIGIDE

    Zafatek

    COPD

    approved small molecule active

    1 trial

  19. Feraccru 30 mg hard capsules

    Lacuna Pharma Pty Ltd

    iron deficient

    approved small molecule active

    1 trial

  20. Fluconazol Accord 50 mg capsules, hard, Diflucan I.V. 2 mg/ml, oplossing voor infusie, Diflucan 100 mg, capsule, hard, Diflucan 10 mg/ml, poeder voor orale suspensie

    Disc Medicine

    Fungal infection

    approved small molecule active

    1 trial

  21. FuKe Qianjin Capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Endometritis

    approved small molecule active

    1 trial

  22. GAVRETO ®(pralsetinib) capsules

    RIGEL PHARMACEUTICALS INC

    Patients with advanced or metastatic solid tumors

    approved small molecule active

    1 trial

  23. Glivec 100 mg hard capsules, Tasigna 150 mg hard capsules

    Fondazione Telethon ETS

    Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)

    approved small molecule active

    1 trial

  24. Guilingji Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oligospermia

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources